SEC Filings

Filing date	Form	Description	View
11/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-027564.pdf 0001415889-24-027564.rtf 0001415889-24-027564.xls
11/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-027567.pdf 0001415889-24-027567.rtf 0001415889-24-027567.xls
11/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-027569.pdf 0001415889-24-027569.rtf 0001415889-24-027569.xls
11/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-027571.pdf 0001415889-24-027571.rtf 0001415889-24-027571.xls
11/22/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-027573.pdf 0001415889-24-027573.rtf 0001415889-24-027573.xls
11/19/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-027297.pdf 0001415889-24-027297.rtf 0001415889-24-027297.xls
11/14/24	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-24-015602.pdf 0001558370-24-015602.rtf 0001558370-24-015602.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
11/14/24	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001013594-24-000953.pdf 0001013594-24-000953.rtf 0001013594-24-000953.xls
11/13/24	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-24-026766.pdf 0001415889-24-026766.rtf 0001415889-24-026766.xls
11/12/24	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-24-116774.pdf 0001104659-24-116774.rtf 0001104659-24-116774.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.